Determinants of Accepting or Rejecting Influenza Vaccination-Results of a Survey Among Ligurian Pharmacy Visitors During the 2023/2024 Vaccination Campaign
- PMID: 40573911
- PMCID: PMC12197350
- DOI: 10.3390/vaccines13060580
Determinants of Accepting or Rejecting Influenza Vaccination-Results of a Survey Among Ligurian Pharmacy Visitors During the 2023/2024 Vaccination Campaign
Abstract
Background/Objectives: Seasonal influenza vaccination is crucial for reducing morbidity, mortality, and healthcare burdens. The 2023/2024 Ligurian vaccination campaign (Italy) utilized an inclusive model involving local health authorities, general practitioners, pediatricians, and pharmacies to enhance accessibility. Our study aimed at focusing on factors influencing vaccine uptake, public attitudes and access to preventive healthcare services. Methods: A cross-sectional survey was conducted among adults (≥18 years) in Ligurian pharmacies visitors during the vaccination campaign. A self-administered structured questionnaire gathered data on demographics, vaccination history, healthcare access, and awareness. Results: The study included 30,499 participants, and the median age with P25-P75 (years) was 62.0 [47.0-74.0]; 54.6% were female. Considering determinants of accepting influenza vaccination, age was identified as a strong independent predictor. Each one-year increase in age was associated with a 3.8% increase in the odds of influenza vaccination (OR 1.03, 95% CI 1.03-1.04, p < 0.001). Compared to individuals who never visited their general practitioners, those who visited "sometimes", "often", or "very often" had significantly higher odds of influenza vaccination (OR 1.54, 1.97, and 1.98, respectively; p < 0.001 for all categories). The strongest predictor of influenza vaccination in the 2023/2024 season was having received the influenza vaccine in the previous season (2022/2023) (OR 71.73, 95% CI 65.38-78.78, p < 0.001). Consistent with increasing age predicting higher influenza vaccination uptake, older age was associated with lower odds of refusing the vaccine due to the belief that "getting or transmitting influenza does not matter" or due to "other or unspecified reasons". In contrast, receipt of the COVID-19 vaccination significantly increased the odds of holding these opinions. Among individuals who cited reasons such as fear of side effects, concerns about vaccine safety, fear of injections, general opposition to vaccines, or doubts about vaccine effectiveness, having received the COVID-19 vaccine was associated with lower odds of citing these as barriers to influenza vaccination. Conclusions: Fear of side effects and perceived unnecessary vaccination are key barriers. Targeted education and the involvement of general practitioners could enhance vaccine acceptance, particularly among hesitant groups.
Keywords: hesitancy; influenza; pharmacies; vaccination; vaccine uptake.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Vaccines for preventing influenza in the elderly.Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD004876. doi: 10.1002/14651858.CD004876.pub4. Cochrane Database Syst Rev. 2018. PMID: 29388197 Free PMC article.
-
Face-to-face interventions for informing or educating parents about early childhood vaccination.Cochrane Database Syst Rev. 2018 May 8;5(5):CD010038. doi: 10.1002/14651858.CD010038.pub3. Cochrane Database Syst Rev. 2018. PMID: 29736980 Free PMC article.
-
Influenza vaccines in immunosuppressed adults with cancer.Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD008983. doi: 10.1002/14651858.CD008983.pub3. Cochrane Database Syst Rev. 2018. PMID: 29388675 Free PMC article.
-
Parents' and informal caregivers' views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence.Cochrane Database Syst Rev. 2017 Feb 7;2(2):CD011787. doi: 10.1002/14651858.CD011787.pub2. Cochrane Database Syst Rev. 2017. PMID: 28169420 Free PMC article.
-
The complex landscape of vaccine hesitancy and hesitant adopters: Quantitative predictors and thematic insights into COVID-19 vaccine attitudes.Hum Vaccin Immunother. 2025 Dec;21(1):2511350. doi: 10.1080/21645515.2025.2511350. Epub 2025 Jun 20. Hum Vaccin Immunother. 2025. PMID: 40540028
References
-
- WHO Influenza. [(accessed on 29 January 2024)]. Available online: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
-
- Maleki F., Welch V., Lopez S.M.C., Cane A., Langer J., Enstone A., Markus K., Wright O., Hewitt N., Whittle I. Understanding the Global Burden of Influenza in Adults Aged 18–64 years: A Systematic Literature Review from 2012 to 2022. Adv. Ther. 2023;40:4166–4188. doi: 10.1007/s12325-023-02610-1. - DOI - PMC - PubMed
-
- Iuliano A.D., Roguski K.M., Chang H.H., Muscatello D.J., Palekar R., Tempia S., Cohen C., Gran J.M., Schanzer D., Cowling B.J., et al. Estimates of global seasonal influenza-associated respiratory mortality: A modelling study. Lancet. 2018;391:1285–1300. doi: 10.1016/S0140-6736(17)33293-2. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials